For some with COVID-19, symptoms can linger for weeks, even months
CORONAVIRUS June 19, 2020
By Helena Oliviero, The Atlanta Journal-Constitution
Excerpt:
Reisman knew about a post-COVID trial for survivors of mild to moderate COVID-19 symptoms. Riley enrolled in the clinical trial for leronlimab, a drug that was originally developed to treat HIV, but is showing promise in the coronavirus fight.
He had four injections in his stomach over two weeks.Riley said he immediately felt better. He returned to a faster pace, his blood pressure returned to normal and the other symptoms – the anxiety, the insomnia — faded.It’s possible he was given a placebo or perhaps it was time that helped him heal, but Riley is confident that it was the leronlimab.
A lab technician works during research on coronavirus, COVID-19, at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, Wednesday, June 17, 2020. Janssen Pharmaceutical hopes to begin clinical trials on a potential vaccine for COVID-19 in the middle of the summer.
Doctor who was also COVID-19 patient Dr. Chris Recknor, a Gainesville internist who runs one of the six sites for the leronlimab clinical trial, is also a COVID-19 survivor. He first got sick in April, starting with an intense headache. Then, he started bumping into things and saw floaters in his eyes. Those aren’t the most common coronavirus symptoms, but he knew something wasn’t right and decided to get tested to, if nothing else, rule out the infectious virus. The test was positive.His conditioned worsened to the point where he thought he might have a heart attack.
He ended up in ER at Northeast Georgia Medical Center three times and was twice admitted for overnight stays.“I felt like my heart was pumping so hard, it felt like it was coming out of my ears,” he said. His physician at the hospital obtained “compassionate use” permission from the Food and Drug Administration to prescribe leronlimab.
https://www.ajc.com/lifestyles/health/for-som...2y3ezEqcN/
CORONAVIRUS June 19, 2020
By Helena Oliviero, The Atlanta Journal-Constitution
Excerpt:
Reisman knew about a post-COVID trial for survivors of mild to moderate COVID-19 symptoms. Riley enrolled in the clinical trial for leronlimab, a drug that was originally developed to treat HIV, but is showing promise in the coronavirus fight.
He had four injections in his stomach over two weeks.Riley said he immediately felt better. He returned to a faster pace, his blood pressure returned to normal and the other symptoms – the anxiety, the insomnia — faded.It’s possible he was given a placebo or perhaps it was time that helped him heal, but Riley is confident that it was the leronlimab.
A lab technician works during research on coronavirus, COVID-19, at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, Wednesday, June 17, 2020. Janssen Pharmaceutical hopes to begin clinical trials on a potential vaccine for COVID-19 in the middle of the summer.
Doctor who was also COVID-19 patient Dr. Chris Recknor, a Gainesville internist who runs one of the six sites for the leronlimab clinical trial, is also a COVID-19 survivor. He first got sick in April, starting with an intense headache. Then, he started bumping into things and saw floaters in his eyes. Those aren’t the most common coronavirus symptoms, but he knew something wasn’t right and decided to get tested to, if nothing else, rule out the infectious virus. The test was positive.His conditioned worsened to the point where he thought he might have a heart attack.
He ended up in ER at Northeast Georgia Medical Center three times and was twice admitted for overnight stays.“I felt like my heart was pumping so hard, it felt like it was coming out of my ears,” he said. His physician at the hospital obtained “compassionate use” permission from the Food and Drug Administration to prescribe leronlimab.
https://www.ajc.com/lifestyles/health/for-som...2y3ezEqcN/
3
